Identifying lupus Patient Subsets Through Immune Cell Deconvolution of Gene Expression Data in Two A...
Identifying lupus Patient Subsets Through Immune Cell Deconvolution of Gene Expression Data in Two Atacicept Phase II Studies
About this item
Full title
Author / Creator
Publisher
Atlanta: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Objective: To use cell‐based gene signatures to identify patients with systemic lupus erythematous (SLE) in the phase II/III APRIL–SLE and phase IIb ADDRESS II trials most likely to respond to atacicept. Methods: A published immune cell deconvolution algorithm based on Affymetrix gene array data was applied to whole blood gene expression from patie...
Alternative Titles
Full title
Identifying lupus Patient Subsets Through Immune Cell Deconvolution of Gene Expression Data in Two Atacicept Phase II Studies
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_add9fe7b98494705a1bf88c69bce3eb1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_add9fe7b98494705a1bf88c69bce3eb1
Other Identifiers
ISSN
2578-5745
E-ISSN
2578-5745
DOI
10.1002/acr2.11594
